TWD 55.0
(1.1%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 491.25 Million TWD | -8.76% |
2022 | 538.43 Million TWD | -8.76% |
2021 | 590.15 Million TWD | 13.47% |
2020 | 520.08 Million TWD | 31.52% |
2019 | 395.44 Million TWD | -4.12% |
2018 | 412.42 Million TWD | 13.18% |
2017 | 364.39 Million TWD | 17.22% |
2016 | 310.86 Million TWD | -10.54% |
2015 | 347.48 Million TWD | 6.21% |
2014 | 327.18 Million TWD | 5.29% |
2013 | 310.73 Million TWD | 7.18% |
2012 | 289.91 Million TWD | -9.79% |
2011 | 321.39 Million TWD | 100.4% |
2010 | 160.37 Million TWD | 32.78% |
2009 | 120.78 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 489.43 Million TWD | 1.63% |
2024 Q1 | 481.57 Million TWD | -1.97% |
2023 Q3 | 528.04 Million TWD | -7.67% |
2023 FY | 491.25 Million TWD | -8.76% |
2023 Q1 | 589.59 Million TWD | 9.5% |
2023 Q2 | 571.9 Million TWD | -3.0% |
2023 Q4 | 491.25 Million TWD | -6.97% |
2022 Q3 | 552.73 Million TWD | -3.31% |
2022 FY | 538.43 Million TWD | -8.76% |
2022 Q4 | 538.43 Million TWD | -2.59% |
2022 Q2 | 571.62 Million TWD | -2.63% |
2022 Q1 | 587.07 Million TWD | -0.52% |
2021 Q1 | 523.68 Million TWD | 0.69% |
2021 FY | 590.15 Million TWD | 13.47% |
2021 Q3 | 614.52 Million TWD | 11.87% |
2021 Q4 | 590.15 Million TWD | -3.96% |
2021 Q2 | 549.33 Million TWD | 4.9% |
2020 Q1 | 483.83 Million TWD | 22.35% |
2020 Q4 | 520.08 Million TWD | -7.44% |
2020 FY | 520.08 Million TWD | 31.52% |
2020 Q2 | 533.13 Million TWD | 10.19% |
2020 Q3 | 561.88 Million TWD | 5.39% |
2019 Q2 | 468.03 Million TWD | 0.23% |
2019 Q4 | 395.44 Million TWD | -25.5% |
2019 FY | 395.44 Million TWD | -4.12% |
2019 Q1 | 466.95 Million TWD | 13.22% |
2019 Q3 | 530.81 Million TWD | 13.41% |
2018 Q4 | 412.42 Million TWD | -7.2% |
2018 FY | 412.42 Million TWD | 13.18% |
2018 Q3 | 444.41 Million TWD | -2.71% |
2018 Q2 | 456.78 Million TWD | 13.32% |
2018 Q1 | 403.1 Million TWD | 10.62% |
2017 Q3 | 427.9 Million TWD | 13.62% |
2017 Q2 | 376.6 Million TWD | 2.45% |
2017 Q1 | 367.6 Million TWD | 18.25% |
2017 FY | 364.39 Million TWD | 17.22% |
2017 Q4 | 364.39 Million TWD | -14.84% |
2016 Q3 | 303 Million TWD | 2.58% |
2016 Q4 | 310.86 Million TWD | 2.59% |
2016 FY | 310.86 Million TWD | -10.54% |
2016 Q1 | 326.1 Million TWD | -6.15% |
2016 Q2 | 295.37 Million TWD | -9.42% |
2015 Q1 | 341.13 Million TWD | 4.26% |
2015 Q2 | 364.01 Million TWD | 6.71% |
2015 Q3 | 363.07 Million TWD | -0.26% |
2015 FY | 347.48 Million TWD | 6.21% |
2015 Q4 | 347.48 Million TWD | -4.29% |
2014 Q3 | 324.87 Million TWD | -1.34% |
2014 Q1 | 304.63 Million TWD | -1.96% |
2014 FY | 327.18 Million TWD | 5.29% |
2014 Q4 | 327.18 Million TWD | 0.71% |
2014 Q2 | 329.29 Million TWD | 8.09% |
2013 FY | 310.73 Million TWD | 7.18% |
2013 Q3 | 376.77 Million TWD | 4.44% |
2013 Q4 | 310.73 Million TWD | -17.53% |
2013 Q1 | 300.6 Million TWD | 3.69% |
2013 Q2 | 360.74 Million TWD | 20.01% |
2012 Q1 | 348.36 Million TWD | 8.39% |
2012 FY | 289.91 Million TWD | -9.79% |
2012 Q4 | 289.91 Million TWD | -0.9% |
2012 Q3 | 292.54 Million TWD | 2.02% |
2012 Q2 | 286.75 Million TWD | -17.68% |
2011 Q1 | 195.58 Million TWD | 21.96% |
2011 Q4 | 321.39 Million TWD | -0.83% |
2011 FY | 321.39 Million TWD | 100.4% |
2011 Q3 | 324.07 Million TWD | 31.98% |
2011 Q2 | 245.55 Million TWD | 25.55% |
2010 FY | 160.37 Million TWD | 32.78% |
2010 Q4 | 160.37 Million TWD | 0.0% |
2009 FY | 120.78 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 705.32 Million TWD | 30.35% |
Maxigen Biotech Inc. | 85.18 Million TWD | -476.697% |
SciVision Biotech Inc. | 87.25 Million TWD | -463.035% |
Pegavision Corporation | 583.47 Million TWD | 15.805% |
Visco Vision Inc. | 606.06 Million TWD | 18.943% |